Evidence map›Paper›PMID 40316365›Full record

ArticleBMJ open2025

Chinese Neonatal Follow-Up Network: a national protocol for follow-up assessment and collaborative research to improve developmental outcomes of high-risk preterm infants.

Qi Zhou, Yun Cao, Nurya Erejep, Long Li, Wenlong Xiu, Jingyun Shi, Rui Cheng, Wenhao Zhou, Shoo K Lee

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi ZhouChildren's Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0002-8151-7305
Yun CaoChildren's Hospital of Fudan University, Shanghai, China yuncao@fudan.edu.cn.
Nurya ErejepNeonatology, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Long LiNeonatology, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Wenlong XiuNeonatology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetric & Gynecology and Pediatrics, Fuzhou, Fujian, China.
Jingyun ShiNeonatology, Gansu Provincial Maternity and Child Care Hospital (Gansu Provincial Central Hospital), Lanzhou, Gansu, China.
Rui ChengNeonatology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Wenhao ZhouNeonatology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Shoo K LeeDepartment of Pediatrics, Mount Sinai Hospital Lawrence and Frances Bloomberg Centre for Women's and Infants' Health, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe objective of the Chinese Neonatal Follow-Up Network (CHNFUN) is to establish a standardised follow-up protocol for the assessment of high-risk preterm infants, and collaborative research aimed at improving early intervention and neurodevelopmental outcomes for preterm infants with gestational age less than 32 weeks in China. The CHNFUN is the first national neonatal follow-up network and has the largest geographically representative cohort from neonatal intensive care units (NICUs) in China. METHODS AND ANALYSIS: A survey of neonatal follow-up clinics participating in CHNFUN was used to inform the development of a standardised protocol for the assessment of high-risk preterm infants in China. Training in the use of assessment tools and data collection was provided to all participating centres. Individual-level neurodevelopmental outcomes data from participating neonatal follow-up clinics will be collected at corrected age, 40 weeks, 3-4 months, 12 months, 18-24 months, 3 years and 6 years of age, using a unique database developed by the CHNFUN and linked to NICU outcomes data in the CHNN Database. Data will be prospectively collected on an ongoing basis from all surviving infants born at <32 weeks' gestation or <1500 g birth weight and discharged from 34 participating NICUs from 1 June 2023. Infant neurodevelopmental outcomes and interinstitutional variations in outcomes will be examined and used to inform quality improvement measures aimed at improving outcomes, development and evaluation of early intervention programmes and other collaborative research, including clinical trials. ETHICS AND DISSEMINATION: This study was approved by the ethics review board of Children's Hospital of Fudan University (#CHFU 2022-112), which was recognised by all participating hospitals. Waiver of consent was granted at all sites. Only non-identifiable patient-level data will be transmitted, and only aggregate data will be reported in CHNFUN reports and publications.

Indexed as

Child DevelopmentInfant, PrematureChildChild, PreschoolChinaEast Asian PeopleFemaleFollow-Up StudiesGestational AgeHumansInfantInfant, NewbornIntensive Care Units, NeonatalNational Health ProgramsResearch DesignChinaFollow-Up StudiesNeonatal intensive & critical careQuality Improvement

Identifiers

PMID40316365
PMCPMC12049985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.